Fleming Medical Ltd is an Irish-owned, family-run company specialized in healthcare devices and consumables. With over 30 years’ experience in the healthcare industry, the company has established itself as an innovator and leader in chronic health conditions by implementing wearable technology into healthcare solutions.
The company is collaborating with NUIG, RCSI, and The Tyndall Institute to develop Dermatrax, which is the world’s first smart wound care dressing. This innovative product utilizes sensors to assess wound viability and sends the information to an app for a more accurate assessment, ultimately reducing wound care costs and patient discomfort.
As pioneers in the field, Fleming Medical remains dedicated to finding groundbreaking ways to enhance patient care by bridging the gap between academic research and practical healthcare needs. Their commitment to providing products and solutions that enhance patient quality of life and deliver clinical efficiency underscores their mantra. The company operates in Health Care, Manufacturing, Medical Devices, and Retail industries.
Since its establishment in 1986, Fleming Medical Ltd has exemplified a strong dedication to pushing the boundaries of healthcare innovation and enhancing patient care.
There is no investment information
No recent news or press coverage available for Fleming Medical Ltd.